𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Intratumoral rhIL-12 administration in head and neck squamous cell carcinoma patients induces B cell activation

✍ Scribed by Carla M.L. van Herpen; Robbert van der Voort; Jeroen A.W.M. van der Laak; Ina S. Klasen; Aniek O. de Graaf; Léon C.L. van Kempen; I. Jolanda M. de Vries; Tjitske Duiveman-de Boer; Harry Dolstra; Ruurd Torensma; Johan H. van Krieken; Gosse J. Adema; Pieter H.M. De Mulder

Publisher
John Wiley and Sons
Year
2008
Tongue
French
Weight
454 KB
Volume
123
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The objectives of this study were to investigate the effects of intratumorally (i.t.) administered recombinant human interleukin‐12 (rhIL‐12) on the distribution and function of B cells in the primary tumors, the locoregional lymph nodes and peripheral blood of head and neck squamous cell carcinoma (HNSCC) patients. The initial characterization of the patients participating in the phase Ib and phase II studies has previously been reported. After rhIL‐12 treatment, fewer secondary follicles with a broader outer region of the mantle zones and an increase in interfollicular B‐blasts were seen in the enlarged lymph nodes compared with control HNSCC patients. The size of the germinal center (GC) was diminished, partly due to a decrease in the number of CD57+ GC cells that have been associated with immune suppression. These changes did not correlate with signs of apoptosis or CXCR5 expression by B cells. Strikingly, in 3 out of 4 IL‐12 treated patients, increased IFN‐γ mRNA expression by B cells was detected. In addition, a highly significant IgG subclass switch was seen in the plasma with more IgG1, less IgG2 and more IgG4, indicating a switch to T helper 1 phenotype. Finally, peritumoral B cell infiltration was a positive prognostic sign for overall survival in the 30 HNSCC patients investigated, irrespective of IL‐12 treatment. In conclusion, these data indicate that after i.t. IL‐12 treatment in HNSCC, significant activation of the B cell and the B cell compartment occurred and that the presence of tumor infiltrating B cells correlated with overall survival of HNSCC patients. © 2008 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Head and neck squamous cell carcinoma in
Head and neck squamous cell carcinoma in childhood
✍ de Carvalho, Marcos Brasilino; Sobrinho, Josias de Andrade; Rapoport, Abrão; Fav 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 2 views

## Background: Squamous cell carcinoma (scc) of the head and neck region is rare in young patients and even less frequent in children 15 years or younger children. the patients reported in the literature are isolated cases and their management is always difficult because there is no large experienc

Efficacy of neck treatment in patients w
Efficacy of neck treatment in patients with head and neck squamous cell carcinoma
✍ Gabriela Buck; Pia Huguenin; Sandro J. Stoeckli 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 2 views

## Abstract ## Background. Treatment of head and neck squamous cell carcinoma (HNSCC) addresses the primary tumor and the lymphatic drainage. Modalities for the neck are neck dissection and/or radiation therapy. In most cases, the neck is treated by the modality that seems more appropriate for the

Radioimmunotherapy in patients with head
Radioimmunotherapy in patients with head and neck squamous cell carcinoma: Initial experience
✍ David R. Colnot; Jasper J. Quak; Jan C. Roos; Remco de Bree; Abraham J. Wilhelm; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 2 views

## Abstract ## Background Despite improvements in locoregional treatment of stages III/IV squamous cell carcinoma of the head and neck (HNSCC), local and distant failure rates remain high. An effective adjuvant therapy is required for these patients. Among novel approaches is radioimmunotherapy, i

Immunoglobulin allotypes in patients wit
Immunoglobulin allotypes in patients with squamous cell carcinoma of the head and neck
✍ Theodorus Ockhuizen; Janardan P. Pandey; Robert W. Veltri; Myron Arlen; H. Hugh 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB 👁 2 views

Gm, A2m, and Km allotypic markers were examined in 40 Caucasian patients with squamous cell carcinomas of the head and neck. Serum IgA levels, the A2m(l) allotypic marker, and antibodies against IgAl, A2m(l), and A2m(2) were measured quantitatively. The frequency of Km(1) was found to be significant